Despite current guidelines discouraging its use, a recent study reveals that many older adults continue to take a daily baby aspirin to prevent first-time heart problems.
Read More
The pivotal outcomes of the RIVER Trial, which stands for Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation, have unveiled that rivaroxaban stands on par with warfarin in terms of effectiveness and impact.
Read More